Characteristics of patients without NHL at enrollment into EuroSIDA
| Characteristics . | All patients without NHL at recruitment, n = 8471 . |
|---|---|
| Sex, % female | 20.7 |
| HIV transmission group | |
| Homosexual, % | 46.6 |
| Intravenous drug use, % | 24.1 |
| Heterosexual, % | 22.2 |
| Race, % Caucasian | 89.9 |
| Other AIDS event before recruitment, % | 30.7 |
| Antiretroviral treatment, % experienced | 77.4 |
| Ever exposed to PI/NNRTI, % | 28.2 |
| Age, y, median (IQR) | 36 (31-43) |
| CD4 count, cells/mm3, median (IQR) | 219 (94-351) |
| Plasma viral load, log10 copies/mL, median (IQR) | 3.3 (2.5-4.4) |
| Characteristics . | All patients without NHL at recruitment, n = 8471 . |
|---|---|
| Sex, % female | 20.7 |
| HIV transmission group | |
| Homosexual, % | 46.6 |
| Intravenous drug use, % | 24.1 |
| Heterosexual, % | 22.2 |
| Race, % Caucasian | 89.9 |
| Other AIDS event before recruitment, % | 30.7 |
| Antiretroviral treatment, % experienced | 77.4 |
| Ever exposed to PI/NNRTI, % | 28.2 |
| Age, y, median (IQR) | 36 (31-43) |
| CD4 count, cells/mm3, median (IQR) | 219 (94-351) |
| Plasma viral load, log10 copies/mL, median (IQR) | 3.3 (2.5-4.4) |
PI indicates protease inhibitor; NNRTI, nonnucleoside reverse transcriptase inhibitor.